A citation-based method for searching scientific literature


List of co-cited articles
681 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4-week, randomized, placebo-controlled trial (EASE-1).
T R Pieber, S Famulla, J Eilbracht, J Cescutti, N Soleymanlou, O E Johansen, H J Woerle, U C Broedl, S Kaspers. Diabetes Obes Metab 2015
99
7

Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study.
Christian S Frandsen, Thomas F Dejgaard, Jens J Holst, Henrik U Andersen, Birger Thorsteinsson, Sten Madsbad. Diabetes Care 2015
50
14


Insulin-associated weight gain in diabetes--causes, effects and coping strategies.
David Russell-Jones, Rehman Khan. Diabetes Obes Metab 2007
297
7


Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial.
Bo Ahrén, Irl B Hirsch, Thomas R Pieber, Chantal Mathieu, Fernando Gómez-Peralta, Troels Krarup Hansen, Areti Philotheou, Sune Birch, Erik Christiansen, Thomas Jon Jensen,[...]. Diabetes Care 2016
68
10

Addition of Liraglutide to Insulin in Patients With Type 1 Diabetes: A Randomized Placebo-Controlled Clinical Trial of 12 Weeks.
Nitesh D Kuhadiya, Sandeep Dhindsa, Husam Ghanim, Aditya Mehta, Antoine Makdissi, Manav Batra, Sartaj Sandhu, Jeanne Hejna, Kelly Green, Natalie Bellini,[...]. Diabetes Care 2016
43
16

Potential causes of weight gain in type 1 diabetes mellitus.
A N Jacob, K Salinas, B Adams-Huet, P Raskin. Diabetes Obes Metab 2006
32
18

Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
6



The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience.
Georgia Pambianco, Tina Costacou, Demetrius Ellis, Dorothy J Becker, Ronald Klein, Trevor J Orchard. Diabetes 2006
298
6


Estimated glucose disposal rate in assessment of the metabolic syndrome and microvascular complications in patients with type 1 diabetes.
Juan J Chillarón, Alberto Goday, Juana A Flores-Le-Roux, David Benaiges, María J Carrera, Jaume Puig, Juan F Cano-Pérez, Juan Pedro-Botet. J Clin Endocrinol Metab 2009
47
12

Obesity and coronary artery calcium in diabetes: the Coronary Artery Calcification in Type 1 Diabetes (CACTI) study.
Ticiana C Rodrigues, Adrienne M Veyna, Michelle D Haarhues, Gregory L Kinney, Marian Rewers, Janet K Snell-Bergeon. Diabetes Technol Ther 2011
22
27



Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.
Sarah D de Ferranti, Ian H de Boer, Vivian Fonseca, Caroline S Fox, Sherita Hill Golden, Carl J Lavie, Sheela N Magge, Nikolaus Marx, Darren K McGuire, Trevor J Orchard,[...]. Circulation 2014
167
6

Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality.
Trevor J Orchard, David M Nathan, Bernard Zinman, Patricia Cleary, David Brillon, Jye-Yu C Backlund, John M Lachin. JAMA 2015
242
6

Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trial.
Satish K Garg, Emily G Moser, Bruce W Bode, Leslie J Klaff, William R Hiatt, Christie Beatson, Janet K Snell-Bergeon. Endocr Pract 2013
66
9

Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition.
Anne L Peters, Elizabeth O Buschur, John B Buse, Pejman Cohan, Jamie C Diner, Irl B Hirsch. Diabetes Care 2015
407
6

Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.
Melanie J Davies, Richard Bergenstal, Bruce Bode, Robert F Kushner, Andrew Lewin, Trine Vang Skjøth, Arne Haahr Andreasen, Christine Bjørn Jensen, Ralph A DeFronzo. JAMA 2015
327
6

Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.
Sarah D de Ferranti, Ian H de Boer, Vivian Fonseca, Caroline S Fox, Sherita Hill Golden, Carl J Lavie, Sheela N Magge, Nikolaus Marx, Darren K McGuire, Trevor J Orchard,[...]. Diabetes Care 2014
196
6

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
6

Dapagliflozin as Additional Treatment to Liraglutide and Insulin in Patients With Type 1 Diabetes.
Nitesh D Kuhadiya, Husam Ghanim, Aditya Mehta, Manisha Garg, Salman Khan, Jeanne Hejna, Barrett Torre, Antoine Makdissi, Ajay Chaudhuri, Manav Batra,[...]. J Clin Endocrinol Metab 2016
39
15

Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes.
Satish K Garg, Robert R Henry, Phillip Banks, John B Buse, Melanie J Davies, Gregory R Fulcher, Paolo Pozzilli, Diane Gesty-Palmer, Pablo Lapuerta, Rafael Simó,[...]. N Engl J Med 2017
183
6

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study.
Paresh Dandona, Chantal Mathieu, Moshe Phillip, Lars Hansen, Diethelm Tschöpe, Fredrik Thorén, John Xu, Anna Maria Langkilde. Diabetes Care 2018
84
7


Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus.
Ian H de Boer, Bryan Kestenbaum, Tessa C Rue, Michael W Steffes, Patricia A Cleary, Mark E Molitch, John M Lachin, Noel S Weiss, John D Brunzell. Arch Intern Med 2008
70
7


[Metabolic syndrome and type-1 diabetes mellitus: prevalence and associated factors].
Juan J Chillarón, Juana A Flores-Le-Roux, Alberto Goday, David Benaiges, María J Carrera, Jaume Puig, Juan F Cano-Pérez, Juan Pedro-Botet. Rev Esp Cardiol 2010
26
19

2000 CDC Growth Charts for the United States: methods and development.
Robert J Kuczmarski, Cynthia L Ogden, Shumei S Guo, Laurence M Grummer-Strawn, Katherine M Flegal, Zuguo Mei, Rong Wei, Lester R Curtin, Alex F Roche, Clifford L Johnson. Vital Health Stat 11 2002
5


Exenatide treatment for 6 months improves insulin sensitivity in adults with type 1 diabetes.
Gayatri Sarkar, May Alattar, Rebecca J Brown, Michael J Quon, David M Harlan, Kristina I Rother. Diabetes Care 2014
50
10

Once-weekly exenatide as adjunct treatment of type 1 diabetes mellitus in patients receiving continuous subcutaneous insulin infusion therapy.
Andrea N Traina, Melinda E Lull, Adrian C Hui, Toni M Zahorian, Jane Lyons-Patterson. Can J Diabetes 2014
32
15

Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus.
David Z I Cherney, Bruce A Perkins, Nima Soleymanlou, Maria Maione, Vesta Lai, Alana Lee, Nora M Fagan, Hans J Woerle, Odd Erik Johansen, Uli C Broedl,[...]. Circulation 2014
678
5

Estimated insulin sensitivity and cardiovascular disease risk factors in adolescents with and without type 1 diabetes.
Brian J Specht, R Paul Wadwa, Janet K Snell-Bergeon, Kristen J Nadeau, Franziska K Bishop, David M Maahs. J Pediatr 2013
54
9

Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines.
Jamie R Wood, Kellee M Miller, David M Maahs, Roy W Beck, Linda A DiMeglio, Ingrid M Libman, Maryanne Quinn, William V Tamborlane, Stephanie E Woerner. Diabetes Care 2013
274
5


Lipoprotein subfraction cholesterol distribution is proatherogenic in women with type 1 diabetes and insulin resistance.
David M Maahs, John E Hokanson, Hong Wang, Gregory L Kinney, Janet K Snell-Bergeon, Ashley East, Bryan C Bergman, Irene E Schauer, Marian Rewers, Robert H Eckel. Diabetes 2010
41
12


Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes.
Arthur T Sands, Brian P Zambrowicz, Julio Rosenstock, Pablo Lapuerta, Bruce W Bode, Satish K Garg, John B Buse, Phillip Banks, Rubina Heptulla, Marc Rendell,[...]. Diabetes Care 2015
120
5

The effect of metformin in overweight patients with type 1 diabetes and poor metabolic control.
Iben Brock Jacobsen, Jan Erik Henriksen, Henning Beck-Nielsen. Basic Clin Pharmacol Toxicol 2009
34
14

Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes.
Kristina I Rother, Lisa M Spain, Robert A Wesley, Benigno J Digon, Alain Baron, Kim Chen, Patric Nelson, H-Michael Dosch, Jerry P Palmer, Barbara Brooks-Worrell,[...]. Diabetes Care 2009
95
5


Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: a randomized, open label study.
K V S Hari Kumar, Altamash Shaikh, Pitambar Prusty. Diabetes Res Clin Pract 2013
59
8

Type 1 diabetes treatment beyond insulin: role of GLP-1 analogs.
Lindsay B Harrison, Pablo F Mora, Gregory O Clark, Ildiko Lingvay. J Investig Med 2013
35
14

Predictors of increasing BMI during the course of diabetes in children and adolescents with type 1 diabetes: data from the German/Austrian DPV multicentre survey.
Elke E Fröhlich-Reiterer, Joachim Rosenbauer, Susanne Bechtold-Dalla Pozza, Sabine E Hofer, Edith Schober, Reinhard W Holl. Arch Dis Child 2014
61
8

Effect of adjunctive pramlintide treatment on treatment satisfaction in patients with type 1 diabetes.
David G Marrero, John Crean, Bei Zhang, Terrie Kellmeyer, Maurice Gloster, Kathrin Herrmann, Richard Rubin, Naomi Fineberg, Orville Kolterman. Diabetes Care 2007
31
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.